Chambal Fertilisers & Chemicals Ltd (CHAMBLFERT) Q1 FY27 Results Analysis: EBITDA Margin Expands 356 bps, Revenue Slips 12%

CompoundingAI Research Updated July 31, 2026 2 min read
Neutral

Chambal Fertilisers & Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 5,027.02 Cr (-11.77% YoY) and PAT growth of +10.27% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 5,027.02 Cr (-11.77% YoY)
PAT (Q1)Rs. 703.49 Cr (+10.27% YoY)
EBITDA margin16.92% (+356 bps YoY)
EPS (Q1)Rs. 17.56 (+10.30% YoY)
Market capRs. 17,863.08 Cr
CMPRs. 445.85

Quarter Snapshot

Standalone EBITDA margin expanded 356 bps YoY to 16.92% despite an 11.8% revenue decline, driven by strong cost management and a sharp turnaround in Complex Fertilizers margins. The TAN project has commenced production, but revenue contribution is yet to materialize, and the IMACID joint venture swung to a loss, weighing on consolidated earnings.

Key Investment Insights

Key Positives

  • Standalone EBITDA margin expanded 356 bps YoY to 16.92%.
  • Complex Fertilizers segment profit surged 67.1% YoY to Rs.238.71 Cr, margin doubled to 13.75% from 6.70%.
  • CPC segment margin expanded to 25.18% from 20.98% YoY.
  • Promoter group acquired over 3,30,000 shares in open market during May-June 2026.
  • TAN project commenced WNA production from June 1, 2026.
  • Total expenses declined 14.76% YoY, faster than revenue decline of 11.77%.

Risk Factors

  • Revenue declined 11.77% YoY due to weak Kharif season demand.
  • Finance costs surged 6.9x YoY to Rs.16.77 Cr due to higher working capital borrowing.
  • Consolidated PAT declined 4.62% YoY, dragged by JV loss (IMACID swung from profit Rs.36.12 Cr to loss Rs.25.10 Cr).
  • Consolidated other income dropped 37.81% YoY to Rs.26.94 Cr.
  • TAN project revenue not yet visible in standalone segment.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now